GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer

Clinical trial NCT02012192 · TERMINATED

Trial details

NCT number: NCT02012192
Sponsor: Medical University Innsbruck
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2014-07-04
Primary completion: 2017-11-30
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.